GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 29/10/2009
PIL Zofran Flexi-amp injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/10/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
  • Change to dosage and administration
Updated on 08/07/2009 and displayed until 29/10/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 31/10/2006 and displayed until 08/07/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 31/05/2006 and displayed until 31/10/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 25/10/2004 and displayed until 31/05/2006
Reasons for adding or updating:
  • Change to drug interactions
Updated on 15/01/2003 and displayed until 25/10/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 06/06/2002 and displayed until 15/01/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 16/10/2001 and displayed until 06/06/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 21/12/2000 and displayed until 16/10/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   ondansetron hydrochloride dihydrate